VANCOUVER, BRITISH COLUMBIA–(Marketwired – July 13, 2016) – Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) (“Calyx” or the “Company”) would like to announce the following corporate changes effective as of June 28, 2016. Mr. Gavin M. McMillan has been appointed to the role of interim Chief Financial Officer. Mr. McMillan will be replacing the current CFO, Ms. Amanda Chow.
Mr. McMillan has over twenty years of business experience, including in the roles of President & CEO and as a director of publicly listed companies. In addition to his experience in executive positions for reporting issuers, he has been directly responsible for managing and growing multi-million dollar lines of business, overseeing measurement, reporting, and financing. Mr. Roger Forde, Chairman and CEO of Calyx commented, “I would like to thank Ms. Chow for her service and wish her all the best in the future.”
About Calyx
Calyx’s wholly-owned subsidiary, Cannigistics Agri-Solutions Corp, is a software development company that has created a software platform tailored to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be the industry leader in agri-software solutions by providing businesses with advanced controls over all aspects of their operations. Additionally, Calyx owns a portfolio of proprietary intellectual property with applications in crop enhancement.
For further information, please visit www.calyxbio.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Roger Forde, Director, President and Chief Executive Officer
Forward-Looking Statements: This document contains certain forward-looking statements concerning Calyx and/or its subsidiaries, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, or performance that may constitute “forward-looking statements” or “forward-looking information” under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx’s control. Such forward-looking statements or information are based on a number of assumptions, which may prove to be incorrect.
Although Calyx believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and described in the forward-looking statements or information.
The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
